Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a high rate of mortality and poor prognosis. Numerous studies have proved that microRNA (miRNA) may play a vital role in a wide range of malignancies, including PDAC, and dysregulated miRNAs, including circulating miRNAs, are a...
Main Authors: | Tao Sun, Xiangyu Kong, Yiqi Du, Zhaoshen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2014/386561 |
Similar Items
-
MicroRNAs in Hepatobiliary and Pancreatic Cancers
by: Yoshimasa eSaito, et al.
Published: (2011-09-01) -
Aberrantly expressed microRNAs in the context of bladder tumorigenesis
by: Jong-Young Lee, et al.
Published: (2016-06-01) -
MicroRNAs in pancreatic cancer diagnosis and therapy
by: Robert Słotwiński, et al.
Published: (2018-10-01) -
Network of microRNAs-mRNAs Interactions in Pancreatic Cancer
by: Elnaz Naderi, et al.
Published: (2014-01-01) -
Clinical implications of microRNAs in human glioblastoma
by: Masahiro eMizoguchi, et al.
Published: (2013-02-01)